Abeona Therapeutics Inc

ABEO

Company Profile

  • Business description

    Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company’s development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

  • Contact

    6555 Carnegie Avenue
    4th Floor
    ClevelandOH44103
    USA

    T: +1 646 813-4701

    E: [email protected]

    https://www.abeonatherapeutics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    136

Stocks News & Analysis

stocks

Insignia Financial: Revised deal still attractive

The offer price is well above our fair value.
stocks

Undervalued ASX income play

Major development projects remain on schedule.
stocks

Going into earnings, is Alphabet stock a buy, a sell, or fairly valued?

With the monetization of GenAI, here’s what we think of Alphabet’s stock

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,001.4059.900.67%
CAC 407,840.5696.151.24%
DAX 4024,193.28151.380.63%
Dow JONES (US)44,502.44179.370.40%
FTSE 1009,065.1041.290.46%
HKSE25,538.07408.041.62%
NASDAQ20,892.6981.49-0.39%
Nikkei 22541,171.321,396.403.51%
NZX 50 Index12,794.0639.68-0.31%
S&P 5006,309.620.000.00%
S&P/ASX 2008,737.2060.000.69%
SSE Composite Index3,582.300.440.01%

Market Movers